DrugBank | Academic Research

Kickstart your biggest breakthroughs

Start researching sooner, explore new approaches faster, and uncover more powerful insights.

The Academic License is free and available for academic researchers. If you find you need broader coverage, our Academic+ License provides even greater breadth and depth of data and support at affordable rates.

	Academic	Academic+
Structured & detailed drug datasets Download full listing	Essential	Essential + Supplementary
Detailed Documentation
Links to Other Sources
Supported Formats	XML	CSV, XML, JSON, SQL
Cost	It's Free!	Affordable Rates
	Get Started	Chat with an ExpertContact Us

Academic

Academic+

Structured & detailed drug datasets
Download full listing

Essential

Essential +
Supplementary

Detailed Documentation

Links to Other Sources

Supported Formats

XML

CSV, XML,
JSON, SQL

Cost

It's Free!

Affordable
Rates

Get Started

Chat with an ExpertContact Us

Trends in GPCR drug discovery: new agents, targets and indications

Alexander S. Hauser, Misty M. Attwood, Mathias Rask-Andersen, Helgi B. Schiöth, David E. Gloriam
Published 27 October 2017, Nature Reviews Drug Discovery

This study sheds new light on drug metabolism by using the DrugBank database to report an analysis of all drugs and agents currently in clinical trials that act via G protein-coupled receptors.

Read Article →

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Mohamed-Elamir F. Hegazy
Published 20 July 2020, Journal of Biomolecular Structure and Dynamics

The DrugBank database which contains 10,036 approved and investigational drugs were explored deeply for potential drugs that target a SARS-CoV-2 enzyme. The database was filtered and uncovered DB02388 and Cobicistat as a promising solution, with the present study highlighting the potentiality of DB02388 and Cobicistat as anti-COVID-19 drugs for clinical trials.

Read Article →

Noelle Kosarek, Eric S. Ho
Published 28 October 2016, Journal of Personalized Medicine

Targeted cancer therapy, a practice that targets the unique mutation profiles in patients, is a challenge for physicians due to the complexity of attempting to prescribe effective unique therapies for each patient. Kosarek and Ho have developed a website that allows users to search for effective drug therapies. The site includes “genes that have been linked to a cancer type” as well as data on specific drugs and clinical trials that can be found within the DrugBank database.

Read Article →

Do better research

Free drug data you can rely on

We set out 15 years ago to organize drug data to make research faster and easier. Today we’re more committed than ever to equipping researchers with what they need to change the future of medicine.

Kickstart your biggest breakthroughs

Find out if you qualify

Are you eligible for an Academic or Academic+ License? You qualify if:

Academic License

The Benefits

Cited 26,500 times and counting

Trends in GPCR drug discovery: new agents, targets and indications

Alexander S. Hauser, Misty M. Attwood, Mathias Rask-Andersen, Helgi B. Schiöth, David E. Gloriam
Published 27 October 2017, Nature Reviews Drug Discovery

In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Mohamed-Elamir F. Hegazy
Published 20 July 2020, Journal of Biomolecular Structure and Dynamics

IDICAP: A Novel Tool for Integrating Drug Intervention Based on Cancel Panel

Noelle Kosarek, Eric S. Ho
Published 28 October 2016, Journal of Personalized Medicine

Get started with our
Academic License

For data science and machine learning,
DrugBank datasets are the industry standard
and trusted around the world.

Drug Datasets

Structured drug data for data science & ML

Drug Datasets

Free drug data for students & profs

Clinical API

Clinical intelligence tool for your software

Drug Search

Customizable drug search options

Drug-Drug Interaction Checker

Search for drug interactions with our API

Drug Allergy

Get drug allergy and cross-sensitivities info

US Drug Labels

Integrate drug manufacturer information

Drug Discovery & Repurposing

Speed up & uncover bigger discoveries with ML

In Silico Testing

Validate targets quickly & accurately

Precision Medicine

Build evidence-based tailored treatment plans

Clinical Trial Matching

Match patients to emerging trials faster

Telehealth

Power your remote care software

Electronic Medical Records

Empower providers with reliable drug information

Help Center

Got questions? We've got answers

Blog

Front-page news and deep-dive content

Customer Stories

Learn how our customers are changing the world

Books & Webinars

Check out hours of guides, books, and more

Publications Directory

Growing list of DrugBank-cited publications

Do better research

Free drug data you can rely on

We set out 15 years ago to organize drug data to make research faster and easier. Today we’re more committed than ever to equipping researchers with what they need to change the future of medicine.

Kickstart your biggest breakthroughs

Find out if you qualify

Are you eligible for an Academic or Academic+ License? You qualify if:

Academic License

The Benefits

Cited 26,500 times and counting

Trends in GPCR drug discovery: new agents, targets and indications

Alexander S. Hauser, Misty M. Attwood, Mathias Rask-Andersen, Helgi B. Schiöth, David E. GloriamPublished 27 October 2017, Nature Reviews Drug Discovery

In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Mohamed-Elamir F. HegazyPublished 20 July 2020, Journal of Biomolecular Structure and Dynamics

IDICAP: A Novel Tool for Integrating Drug Intervention Based on Cancel Panel

Noelle Kosarek, Eric S. HoPublished 28 October 2016, Journal of Personalized Medicine

Get started with our Academic License

For data science and machine learning, DrugBank datasets are the industry standard and trusted around the world.

Alexander S. Hauser, Misty M. Attwood, Mathias Rask-Andersen, Helgi B. Schiöth, David E. Gloriam
Published 27 October 2017, Nature Reviews Drug Discovery

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Mohamed-Elamir F. Hegazy
Published 20 July 2020, Journal of Biomolecular Structure and Dynamics

Noelle Kosarek, Eric S. Ho
Published 28 October 2016, Journal of Personalized Medicine

Get started with our
Academic License

For data science and machine learning,
DrugBank datasets are the industry standard
and trusted around the world.